stockrowArdelyx, Inc. (ARDX) vs OmniAb, Inc. (OABI)
- Ardelyx, Inc. ARDX 2.86 −4.35%
- OmniAb, Inc. OABI 5.02 +3.93%
Ardelyx, Inc. and OmniAb, Inc. are both Biotechnology companies. Ardelyx, Inc. and OmniAb, Inc. are of similar size ($751.6M and $704.5M). OmniAb, Inc. grew revenue faster over the last twelve months: 90.6% against 17.6%. Ardelyx, Inc. has the higher net margin (−11.9% vs −108.1%) and the lower return on invested capital (−17.2% vs −15.8%). Across the 17 metrics below, OmniAb, Inc. leads on 12 and Ardelyx, Inc. on 5.
Valuation
Profitability
| Metric | ARDX | OABI | Biotechnology median |
|---|---|---|---|
| Gross margin | 94.46% | 97.65% | 68.51% |
| Operating margin | (7.71%) | (115.89%) | 0.00% |
| Net margin | (11.85%) | (108.11%) | 0.00% |
| Free cash flow margin | (3.41%) | 5.92% | 0.00% |
| Return on equity | (34.85%) | (16.51%) | (51.96%) |
| Return on assets | (10.33%) | (14.48%) | (46.06%) |
| Return on invested capital | (17.21%) | (15.75%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack